Research theme for competitive and other funds (9):
2016 - 2019 Development of fundamental therapy for dopamine-related disorders targetting novel protein complex V-1/CP
2008 - 2010 Elucidation of novel molecular regulatory mechanisms underlying tyrosine hydroxylase functional expression and development of therapeutics for the CNS neurodegenerative disorders
2007 - 2008 Basic research for finding the mechanism of paradox appeared in Controlling asthma
2004 - 2005 Elucidation of physiological significance of a novel regulator of neuronal functions and its application to functional regeneration of brain
2004 - 2004 新しい医薬資源からの抗がん性物質の探索と分子標的の解明
2003 - 2003 新しい医薬資源からの抗がん性物質の分子標的の解明
2002 - 2002 新しい医薬資源からの抗腫瘍性天然物の探索とその分子標的の解明
2001 - 2002 神経細胞の分化を制御する微量天然生理活性物質の探索およびその作用解析
1997 - 1999 Regulation of Mechanisms underlying signal transduction via sigma-1 receptor and activity of Tyrosine Hydroxylase.
Show all
Papers (129):
Junpei Kobayashi, Takafumi Hasegawa, Naoto Sugeno, Shun Yoshida, Tetsuya Akiyama, Koki Fujimori, Hiroyasu Hatakeyama, Yasuo Miki, Arata Tomiyama, Yasushi Kawata, et al. Extracellular α-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2019. 33. 9. 10240-10256